The effect of normobaric hyperoxia on superoxide dismutase activity and neurological deficits in an animal model of Huntington disease

Physiology and Pharmacology

Volumn 13, Issue 1, 2009, Pages 18-27

  Bigdeli, Mohammad Reza ^a   Rahnema, Mehdi ^a  

^a ISLAMIC AZAD UNIVERSITY   (Iran)

Author keywords

Brain preconditioning; Excitotoxicity; Huntington; Neurological deficits; Normobaric hyperoxia; Tolerance

Indexed keywords

3 NITROPROPIONIC ACID; SUPEROXIDE DISMUTASE;

AMBIENT AIR; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BODY EQUILIBRIUM; BRAIN TISSUE; CELL VIABILITY; CONDITIONING; CONTROLLED STUDY; ENZYME ACTIVITY; HUNTINGTON CHOREA; HYPEROXIA; NEUROLOGIC DISEASE; NONHUMAN; RAT;

EID: 77957864023     PISSN: 17350581     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (30)

1. Alexi T, Hughes PE, Faull RL, Williams CE, 3- Nitropropionic acid's lethal triplet: cooperative pathways of neurodegeneration. Neuroreport 9 (1998) R57-R64. (Pubitemid 28387125)
2. Beal MF, Brouillet E, Jenkins BG, Ferrante RJ, Kowall NW, Miller JM, Storey E, Srivastava R, Rosen BR, Hyman BT, Neurochemical and histologic characterization of striatal excitotoxic lesions produced by the mitochondrial toxin 3-nitropropionic acid. J Neurosci 13 (1993) 4181-4192.
3. Bigdeli MR, Hajizadeh S, Froozandeh M, Rasulian B, Heidarianpour A, Khoshbaten A, Prolonged and intermittent normobaric hyperoxia induce different degrees of ischemic tolerance in rat brain tissue. Brain Res 1152 (2007) 228-233.
4. Bigdeli MR, Hajizadeh S, Froozandeh M, Rasulian B, Heidarianpour A, Khoshbaten A, Normobaric hyperoxia induces ischemic tolerance and upregulation of glutamate transporters in the rat brain and serum TNF-a level. Exp Neurol (2008) in press.
5. Bigdeli MR, Khoshbaten A, In vivo preconditioning with normobaric hyperoxia induces ischemic tolerance partly by triggering TACE/TNF-α/NF- κB. Neuroscience 153 (2008) 671-678.
6. Borlongan CV, Koutouzis TK, Sanberg PR, 3- Nitropropionic acid animal model and Huntington's disease. Neurosci Biobehav Rev 21 (1997) 289-293. (Pubitemid 27225151)
7. Borlongan CV, Nishino H, Sanberg PR, Systemic, but not intraparenchymal, administration of 3-nitropropionic acid mimics the neuropathology of Huntington's disease: a speculative explanation. Neurosci Res 28 (1997) 185-189. (Pubitemid 27280918)
8. Bowes M, Zivin J, Tothlein R, Monoclonal antibody to ICAM-1 adhesion site reduces neurological damage in a rabbit cerebral embolism stroke model. Stroke 25 (1994) 869-876.
9. Bradford MM, A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 72 (1976) 248-54.
10. Brouillet E, Conde F, Beal MF, Hantraye P, Replicating Huntington's disease phenotype in experimental animals. Prog Neurobiol 59 (1999) 427-468.
11. Brouillet E, Jenkins BG, Hyman BT, Ferrante RJ, Kowall NW, Srivastava R, Roy DS, Rosen BR, Beal MF, Age-dependent vulnerability of the striatum to the mitochondrial toxin 3-nitropropionic acid. J Neurochem 60 (1993) 356-359.
12. Browne SE, Bowling AC, MacGarvey U, Baik MJ, Berger SC, Muqit MM, Bird ED, Beal MF, Oxidative damage and metabolic dysfunction in Huntington's disease: selective vulnerability of the basal ganglia. Ann Neurol 41 (1997) 646-653.
13. French SJ, Humby T, Horner CH, Sofroniew M, Rattry M, Hippocampal neurotrofin and trk receptor mRNA level are altered by local administration of nicotine carbachol and pilocarpine. Brain Res 67 (1999) 124-136.
14. Genet S, Kale RK, Baquer NZ, Alterations in antioxidant enzymes and oxidative damage in experimental diabetic rat tissues: effect of vanadate and fenugreek (Trigonellafoenum graecum). Mol Cell Biochem 236 (2002):7-12. (Pubitemid 34851222)
15. Guyot MC, Hantraye P, Dolan R, Pal¢ S, Maziere M, Brouillet E, Quanti¢able bradykinesia, gait abnormalities and Huntington's disease-like striatal lesions in rats chronically treated with 3-nitropropionic acid. Neuroscience 79 (1997) 45-56. (Pubitemid 27244999)
16. Haik KL, Shear DA, Scheroder U, Sabel BA, Dunbar GL, Quinolinic acid released from polymeric brain implants causes behavioral and neuroanatomical alterations in rodent model of Huntington's disease. Exp Neurol 163 (2000) 430-439.
17. Heales SJ, Bolanos JP, Stewart VC, Brookes PS, Land JM, Clark JB, Nitric oxide, mitochondria and neurological disease. Biochim Biophys Acta 1410 (1999) 215-228. (Pubitemid 29078606)
18. Helms A, Whelan H, Torbey M, Hyperbaric oxygen therapy of cerebral ischemia. Cerebrovascular dis 20 (2005) 417-426. (Pubitemid 41675018)
19. Hicky MA, Reynolds GP, Morton AJ, The role of dopamine in motor symptoms in the R6/2 transgenic mouse model of Huntington's disease. Neurochem 81 (2002) 46-59.
20. Kitagawa K, Matsumoto M, Tagaya M, Hata R, Ueda H, Niinobe M, Handa N, Fukunaga R, Kimura K, Mikoshiba K, Ischemic tolerance phenomenon found in the brain. Brain Res 528 (1990) 21-24.
21. Ostrowski R, Colohan A, Zhang J, Mechanisms of hyperbaric oxygen-induces neuroprotection in a rat model of subarachnoid hemorrhage. J Cereb Blood Flow & Metab 25 (2005) 554-571. (Pubitemid 40562929)
22. Ouary S, Bizat N, Altairac S, Menetrat H, Mittoux V, Conde F, Hantraye P, Brouillet E, Major strain di¡erences in response to chronic systemic administration of the mitochondrial toxin 3-nitropropionic acid in rats: implications for neuroprotection studies. Neuroscience 97 (2000) 521-530. (Pubitemid 30320758)
23. Pradillo J, Hurtado O, Romera C, Cardenas A, Fernandez-Tome P, Alonso-Escolano D, Lorenzo P, Moro M, Lizasoain, TNF-R1 mediayes increased neuronal membrane EAAT3 experession after in vivo cerebral ischemic preconditioning. Neuroscience 138 (2006) 1171-1178
24. Ravikumar R, Fugaccia I, Scheff SW, Geddes JW, Srinvasan C, Toborek M, Nicotine attenuates morphological deficits in a contusion model of spinal cord injury. J Neurotruma 22 (2005) 240-251. (Pubitemid 40333518)
25. Rivlin AS, Tator CH. Objective clinical assessment of motor function after experimental spinal cord injury in the rat. J Neurosurg 47 (1977) 577-581.
26. Shear DA, Dong J, Gundy CD, Haik-Creguer KL, Dunbar GL, Comparison of intrastriatal injections of quinolinic acid and 3-nitropropionic acid for use in animal models of Huntington's disease. Prog Neuropsychopharmacol Biol Psychiat 22 (1998) 1217-1240.
27. Vis JC, Verbeek MM, De Waal W, Ten Donkelear HJ, Kremer HPH, 3-nitropropionic acid induces a spectrum of Huntington's disease like neuropathology in rat striatum. Neuropathol Appl Neurobiol 25 (1999) 513-521.
28. Wada K, Kiyazawa T, Nomura N, Yano A, Tsuzuki N, Nawashiro H, Shima K, Mn-SOD and Bcl-2 expression after repeated hyperbaric oxygenation. Acta Neurochir Suppl 76 (2000) 285-290
29. Xia E, Rao G, Van Remmen H, Heydari AR, Richardson A, Activities of antioxidant enzymes in various tissues of male Fischer 344 rats are altered by food restriction. J Nutr 125 (1995) 195-201.
30. Zhang R, Chopp M, Jiang N, Tang W, Protak J, Manning A, Anderson D, Anti-intercellular adhesion molecule-1 antibody reduces ischemic cell damage after transient but not permanent middle cerebral artery occlusion in the wistar rat. Stroke 26 (1995) 1438-1443.